Superworth

Insulet EV/EBIT PODD

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2018.

Today, Nov 2, 2026
21.0×
8-year median
193×
Against its 8-year history
4th
percentile: 0 is its lowest day, 100 its highest
8-year range
18.1× to 496×
Peer median
17.8×

Insulet's EV/EBIT is 21.0× as of Nov 2, 2026.

That is below its 8-year median of 193×, lower than on 96% of days in the last 8 years.

Over that time it ranged from 18.1× in Oct 2026 to 496× in Feb 2019.

The median for 10 medical instruments and supplies stocks of a similar size is 17.8×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far21.0×18.1×47.1×
202547.1×47.1×68.3×
202462.4×48.6×94.2×
202399.8×69.0×278×
2022209×98.0×256×
2021272×228×383×
2020219×190×285×
2019226×171×496×
2018468×445×492×

Against its peers

Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.

CompanyEV/EBIT
PODDInsulet21.0×
GMEDGlobus Medical15.9×
ALGNAlign Technology16.2×
COOCooper Companies17.2×
PENPenumbra65.2×
SOLVSolventum8.3×
MSAMSA Safety18.4×
HAEHaemonetics27.1×
MMSIMerit Medical Systems26.0×
VNTVontier11.5×
BMIBadger Meter26.9×
Peer median17.8×

Where Insulet ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Insulet

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.